StockData
Advanced Biomed Inc. logo

Advanced Biomed Inc. (ADVB) income statement

ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$2.15+0.05 (+2.62%)

Close on Nov 18, 2026Market cap $3.56MP/E 0.4Yield –

Advanced Biomed Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin
–
Operating margin
-4883.8%
Net margin
5231.3%
Return on equity, FY2026
84.8%

Financial strength

Current ratio
9.33
Debt to equity
–
Debt to assets
–
Cash to current liabilities
26.2%

Valuation

P/E ratio
0.4
Price to sales
–
Price to book
0.29
Dividend yield
–

See a number that looks wrong?